CIK 0001785530
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823523180
- Phone
- +1 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-30 | Morrison Briggs Director | Grant or award · Stock Option (right to buy) | +23,200 | 23,200 | ||
| 2021-04-30 | Lubman Ellen Chief Business Officer | Grant or award · Stock Option (right to buy) | +48,455 | 48,455 | ||
| 2021-04-30 | HICKLIN DANIEL J | Grant or award · Stock Option (right to buy) | +155,416 | 155,416 | ||
| 2021-04-30 | EVNIN LUKE Director | Grant or award · Stock Option (Right to Buy) | +23,200 | 23,200 | ||
| 2021-02-12 | Trost Timothy W. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +247,812 | 247,812 | ||
| 2020-12-23 | EVNIN LUKE Director | Purchase · Series B Preferred Stock | +7,939,970 | 7,939,970 | ||
| 2020-12-23 | Asanuma Sakae Director | Purchase · Series B Preferred Stock | +3,797,921 | $0.92 | $3.5M | 3,797,921 |
| 2020-12-23 | Lazarus Alon Director | Purchase · Series B Preferred Stock | +3,560,551 | $0.92 | $3.3M | 3,560,551 |
| 2020-12-08 | Leonard Reid Chief Operating Officer | Grant or award · Stock Option (right to buy) | +99,163 | 99,163 | ||
| 2020-12-08 | Isaacs Randi Chief Medical Officer | Grant or award · Stock Option (right to buy) | +140,208 | 140,208 | ||
| 2020-12-08 | Seidel-Dugan Cynthia Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +99,163 | 99,163 | ||
| 2020-12-08 | Lubman Ellen Chief Business Officer | Grant or award · Stock Option (right to buy) | +118,781 | 118,781 | ||
| 2020-12-08 | HICKLIN DANIEL J | Grant or award · Stock Option (right to buy) | +727,377 | 727,377 | ||
| 2020-11-09 | Isaacs Randi Chief Medical Officer | Grant or award · Stock Option (right to buy) | +176,966 | 176,966 | ||
| 2020-08-03 | Lubman Ellen Chief Business Officer | Grant or award · Stock Option (right to buy) | +145,531 | 145,531 |
Page 17 of 17 · 335 trades